Evidence map›Paper›PMID 35577675›Full record

ReviewTrends in biochemical sciences2022

Time to target the circadian clock for drug discovery.

Emil Sjulstok Rasmussen, Joseph S Takahashi, Carla B Green

Abstract readReview
In one paragraph

Review in Trends in biochemical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Small Molecule Regulation of CLOCK:BMAL1 DNA Binding Activity.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Association ofInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Tuning the clock with BMAL1 ligand.Nature chemical biology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Development of compounds for targeted degradation of mammalian cryptochrome proteins.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emil Sjulstok RasmussenDepartment of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Joseph S TakahashiDepartment of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Carla B GreenDepartment of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Carla.Green@UTSouthwestern.edu.

Funding

Molecular mechanisms of mammalian circadian clock function - Renewal - 1R35GM127122 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Carla B. Green · 2018 to 2026
$6.0M
Role of the circadian protein Nocturnin in modulating oxidative stress in substantia nigra dopaminergic neuronsR21NS115482 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI GREEN, CARLA B. · 2020 to 2020
$450k
Circadian Rhythms and LifespanR56AG072736 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI GREEN, CARLA B., TAKAHASHI, JOSEPH S · 2021 to 2021
$333k
NIA NIH HHS R56 AG072736NIGMS NIH HHS R35 GM127122NINDS NIH HHS R21 NS115482
6 · The paper itself

Abstract

The circadian clock is an intracellular timekeeping device that drives daily rhythms in diverse and extensive processes throughout the body. The clock mechanism comprises a core transcription/translation negative feedback loop that is modulated by a complex set of additional interlocking feedback loops. Pharmacological manipulation of the clock may be valuable for treating many maladies including jet lag, shift work and related sleep disorders, various metabolic diseases, and cancer. We review recent identification of small-molecule clock modulators and discuss the biochemical features of the core clock that may be amenable to future drug discovery.

Indexed as

Circadian ClocksCircadian RhythmDrug DiscoveryBMAL1CLOCKCRYPERrhythms

Identifiers

PMID35577675
PMCPMC9378619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.